PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 73 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $66,000 | -77.6% | 21,600 | -72.3% | 0.01% | -81.4% |
Q4 2021 | $295,000 | +619.5% | 77,985 | +622.1% | 0.04% | +616.7% |
Q2 2021 | $41,000 | -43.1% | 10,800 | -46.0% | 0.01% | -60.0% |
Q4 2019 | $72,000 | -51.0% | 20,000 | -53.7% | 0.02% | -60.5% |
Q3 2019 | $147,000 | -30.7% | 43,231 | -3.9% | 0.04% | -38.7% |
Q2 2019 | $212,000 | +40.4% | 45,000 | 0.0% | 0.06% | +40.9% |
Q1 2019 | $151,000 | +7.1% | 45,000 | -15.3% | 0.04% | +22.2% |
Q4 2018 | $141,000 | -44.0% | 53,159 | +18.1% | 0.04% | -25.0% |
Q3 2018 | $252,000 | +10.5% | 45,000 | 0.0% | 0.05% | -56.8% |
Q2 2018 | $228,000 | +67.6% | 45,000 | +125.0% | 0.11% | +246.9% |
Q1 2018 | $136,000 | – | 20,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
CM Management, LLC | 649,400 | $193,521 | 0.20% |
BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |